Brinter
Brinter is a revolutionary modular 3D bioprinter for global markets. A comprehensive 3D bio solution offering variable printing modalities in a single printing platform. Innovating medical, pharmaceutical, and life science industries. Brinter™ will extend the human life span and relieve famine in the world. Brinter™ is a revolutionary modular 3D-bio printer for global markets designed for medical, pharmaceutical, and life science industries. Using different bio inks, Brinter™ can be used to print anything from living tissues and transplantable organs to personalized medicine and food. Built alongside globally recognized medical facilities, educational institutes, and research centers. Our partners and clients are on the bleeding edge of bio innovations. Modular technology allows for infinite future modules for new bio applications, client ideas, and improvements. Revolutionize your industry with Brinter™ bioprinters.
Brinter is a revolutionary modular 3D bioprinter for global markets. A comprehensive 3D bio solution offering variable printing modalities in a single printing platform. Innovating medical, pharmaceutical, and life science industries. Brinter™ will extend the human life span and relieve famine in the world. Brinter™ is a revolutionary modular 3D-bio printer for global markets designed for medical, pharmaceutical, and life science industries. Using different bio inks, Brinter™ can be used to print anything from living tissues and transplantable organs to personalized medicine and food. Built alongside globally recognized medical facilities, educational institutes, and research centers. Our partners and clients are on the bleeding edge of bio innovations. Modular technology allows for infinite future modules for new bio applications, client ideas, and improvements. Revolutionize your industry with Brinter™ bioprinters.
Brinter has raised $1.5M across 1 round. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Brinter is featured in
Similar companies
They are a pioneering company driven by a passion for innovation and a commitment to solving their partners’ problems.Their mission is to support pharma companies as they develop life-changing medicines, by overcoming drug development & delivery challenges.
StemSight is a startup focusing on cell therapy in Tampere, Finland, where they are working on innovative treatments for blindness.
Herantis Pharma is a company focused on addressing medical needs that have not been met by current treatments.
Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapy platform, based on genetically modified safe lactic acid bacteria, addresses unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammation. After successfully completing our Phase 1 clinical study in Diabetic Foot Ulcer (DFU) patients with our lead clinical product AUP-16, our DFU Phase 2 study is ongoing in Italy, Germany and Poland. Venous Ulcers and other ulcers will follow. In Oncology, we are building on impressive pre-clinical data with Oncolytic Bacteria lead candidate AUP-55, which shows increased survival in Ovarian Cancer and peritoneal carcinomatosis. Our pipeline also includes Inflammation, at discovery stage.
Eevia Health is a Nordic life science company based in Finland and Norway, with headquarters in Seinäjoki and production facilities in Kauhajoki. They address key health issues using bioactive ingredients sourced from natural, organic materials found in the Arctic. Their mission is to promote happiness and wellness by incorporating organic ingredients from the Arctic forests, known for their powerful antioxidants that can reduce inflammation and lower the risk of future diseases. Eevia Health collaborates with universities and research organizations in Scandinavia to develop high-quality products focused on anti-inflammation and anti-oxidation in the body. They believe that good health not only supports current lifestyle demands but also contributes to better business.
Nexstim is a medical device company focused on image-guided transcranial magnetic stimulation, dedicated to enhancing the lives of patients with unmet clinical needs. Their SmartFocus TMS technology is tailored for treating major depressive disorder. Established in 2000, Nexstim is based in Helsinki, Southern Finland.
Enifer is a company that specializes in using fungal fermentation to create products from byproducts of the agrifood industry. Their process allows for the production of a high-quality protein from fish byproducts that can be used as an alternative to soy in fish feed, addressing ecological issues associated with soy cultivation such as deforestation.
Solar Foods is a food-tech startup that focuses on utilizing a technology that involves using electricity to generate hydrogen. This hydrogen is then mixed with carbon dioxide, water, vitamins, and minerals to produce microbial biomass, which can be consumed as protein. The company creates a protein called Solein, which serves as a sustainable alternative to animal-based proteins. Solein is made by extracting elements such as CO2, water, and nitrogen from the air and using electricity. The protein is cultivated through gas fermentation, extracting edible calories from microbes that oxidize hydrogen.
Onego Bio is a company based in the US and Finland that is transforming the food industry by utilizing precision fermentation to create animal-free egg protein. Their product, Bioalbumen, is a sustainable protein option that matches the taste and nutritional value of real eggs, while also offering superior functional properties and a significantly smaller environmental impact. Onego's innovative technology is in high demand in the food industry, and has received recognition for its groundbreaking contributions, including winning Fast Company's 2023 World Changing Ideas awards. Furthermore, Onego is a founding member of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.
Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated by leading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.